Paper39622151
Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy.
Taurin S and 5 others. Transl Oncol, 2025. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy. Papers, record 39622151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39622151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References187
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31554955 | Generation of blood vessel organoids from human pluripotent stem cells. | Nat Protoc | 2019 | https://conductscience.org/library/papers/31554955 | PubMed |
| 2 | 38791887 | Driver Mutations in Pancreatic Cancer and Opportunities for Targeted Therapy. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38791887 | PubMed |
| 3 | 34916298 | Adult mouse and human organoids derived from thyroid follicular cells and modeling of Graves' hyperthyroidism. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/34916298 | PubMed |
| 4 | 25201530 | Organoid cultures derived from patients with advanced prostate cancer. | Cell | 2014 | https://conductscience.org/library/papers/25201530 | PubMed |
| 5 | 34142093 | Applications of Organoids for Cancer Biology and Precision Medicine. | Nat Cancer | 2020 | https://conductscience.org/library/papers/34142093 | PubMed |
| 6 | 26935695 | High-fat diet enhances stemness and tumorigenicity of intestinal progenitors. | Nature | 2016 | https://conductscience.org/library/papers/26935695 | PubMed |
| 7 | 29438693 | Cellular Pliancy and the Multistep Process of Tumorigenesis. | Cancer Cell | 2018 | https://conductscience.org/library/papers/29438693 | PubMed |
| 8 | 26458176 | Nephron organoids derived from human pluripotent stem cells model kidney development and injury. | Nat Biotechnol | 2015 | https://conductscience.org/library/papers/26458176 | PubMed |
| 9 | 31101504 | Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors. | Gynecol Oncol | 2019 | https://conductscience.org/library/papers/31101504 | PubMed |
| 10 | 38840027 | iPSC-derived hindbrain organoids to evaluate escitalopram oxalate treatment responses targeting neuropsychiatric symptoms in Alzheimer's disease. | Mol Psychiatry | 2024 | https://conductscience.org/library/papers/38840027 | PubMed |
| 11 | 36194178 | Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy. | Ann Med | 2022 | https://conductscience.org/library/papers/36194178 | PubMed |
| 12 | 28526679 | Succession of transiently active tumor-initiating cell clones in human pancreatic cancer xenografts. | EMBO Mol Med | 2017 | https://conductscience.org/library/papers/28526679 | PubMed |
| 13 | 28878359 | Directed Differentiation of Human Induced Pluripotent Stem Cells into Fallopian Tube Epithelium. | Sci Rep | 2017 | https://conductscience.org/library/papers/28878359 | PubMed |
| 14 | 30500539 | Inflammatory Cytokine TNFα Promotes the Long-Term Expansion of Primary Hepatocytes in 3D Culture. | Cell | 2018 | https://conductscience.org/library/papers/30500539 | PubMed |
| 15 | 36351055 | Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic Malignancies. | Cancer Discov | 2023 | https://conductscience.org/library/papers/36351055 | PubMed |
| 16 | 33972779 | Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence. | Nat Genet | 2021 | https://conductscience.org/library/papers/33972779 | PubMed |
| 17 | 36694344 | Preclinical patient-derived modeling of castration-resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient disease. | Mol Oncol | 2023 | https://conductscience.org/library/papers/36694344 | PubMed |
| 18 | 23954708 | Animal models of human disease: challenges in enabling translation. | Biochem Pharmacol | 2014 | https://conductscience.org/library/papers/23954708 | PubMed |
| 19 | 36591461 | Screening of an individualized treatment strategy for an advanced gallbladder cancer using patient-derived tumor xenograft and organoid models. | Front Oncol | 2022 | https://conductscience.org/library/papers/36591461 | PubMed |
| 20 | 34376194 | Ultrastructural analysis of breast cancer patient-derived organoids. | Cancer Cell Int | 2021 | https://conductscience.org/library/papers/34376194 | PubMed |
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42909412 | Reconstructing the Tumor Mechanical Microenvironment in Organoids: From Mechanical Cues to Biomimetic Modeling and Therapeutic Insights. | Int J Med Sci | 2026 | https://conductscience.org/library/papers/42909412 | PubMed |
| 42711723 | Three-dimensional spheroid models in breast cancer: tumor microenvironment complexity, cancer stem cell-driven resistance, and translational model integration. | J Transl Med | 2026 | https://conductscience.org/library/papers/42711723 | PubMed |
| 42664955 | Tumor-on-chip as a personalized platform for rapid drug testing in breast cancer. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42664955 | PubMed |
| 42581900 | Precision oncology in the treatment of patients with bone sarcomas: an up-to-date narrative review. | Explor Target Antitumor Ther | 2026 | https://conductscience.org/library/papers/42581900 | PubMed |
| 42564263 | Tumor organoid-immune cell co-culture systems for precision oncology. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42564263 | PubMed |
| 42558389 | Patient-derived organoids in functional precision oncology: from experimental models to clinical decision-making. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42558389 | PubMed |
| 42431843 | Evaluation of Mutation Risk Using Patient-Derived Organoids in Patients With Lynch Syndrome. | Int J Cancer | 2026 | https://conductscience.org/library/papers/42431843 | PubMed |
| 42373929 | Organoid technology in cancer research. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42373929 | PubMed |
| 42310800 | iPSC-derived cardiac organoids for drug cardiotoxicity evaluation and efficacy prediction in myocardial infarction and cardiac hypertrophy models. | Stem Cell Res Ther | 2026 | https://conductscience.org/library/papers/42310800 | PubMed |
| 42249357 | Deconstructing cancer in 3D: models, mechanisms, and personalized solutions. | Mol Cancer | 2026 | https://conductscience.org/library/papers/42249357 | PubMed |
| 42215821 | New Frontiers of Drug Development Through the Use of New Approach Methodologies. | AAPS J | 2026 | https://conductscience.org/library/papers/42215821 | PubMed |
| 42212169 | Re-evaluating breast malignant pleural effusion: toward evidence-based, precision-aligned care with organoids. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/42212169 | PubMed |
| 42193932 | The Organoid Decade: Leveraging 3D Patient-Derived Organoids to Bridge the Translational Gap in Triple-Negative Breast Cancer: A Systematic Review. | Cells | 2026 | https://conductscience.org/library/papers/42193932 | PubMed |
| 42130463 | The Role that Biobanks Can Play in Driving Animal-Free Biomedical Research. | Expert Rev Mol Med | 2026 | https://conductscience.org/library/papers/42130463 | PubMed |
| 42094265 | Organoid research: new concepts and new technologies. | Burns Trauma | 2026 | https://conductscience.org/library/papers/42094265 | PubMed |
| 42060212 | A patient-derived organoid model identifies TP53-dependent gemcitabine sensitivity in spinal chordoma. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42060212 | PubMed |
| 42042543 | Molecular Oncodiagnostics in Precision Oncology: Integrating Tumor Transcriptomics, Patient Pharmacogenetics, and Ex Vivo Chemoresistance Testing to Improve Individual Chemotherapy Response. | J Pers Med | 2026 | https://conductscience.org/library/papers/42042543 | PubMed |
| 42040583 | The patient journey and guideline-concordant care in colorectal cancer-is current practice enough? | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42040583 | PubMed |
| 41983356 | Emerging Frontiers in Ovarian Organoids: Bridging Development,Function, and Disease Modeling: A Review. | Int J Fertil Steril | 2026 | https://conductscience.org/library/papers/41983356 | PubMed |
| 41874465 | Understanding and Overcoming Antibody-Drug Conjugate Resistance: Biological Mechanisms and Emerging Analytical Frameworks in Breast Cancer. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41874465 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39622151
GET https://conductscience.org/api/papers/v1/39622151/references?page=2